Investigator
Douglas F Nixon
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · funded by NIDA, NIA, NCI
- Companies
- 5
- Grants
- 6
- Non-dilutive funding
- $3.5M
- First award
- Jul 15, 2020
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Jul 15, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- FEINSTEIN INSTITUTE FOR MEDICAL RESEARCHMomentum in another area
NeuroGrant-only
- FEINSTEIN INSTITUTE FOR MEDICAL RESEARCHMomentum in another area
NeuroGrant-only
- FEINSTEIN INSTITUTE FOR MEDICAL RESEARCHMomentum in another area
NeuroGrant-only
- FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH24momentum
OncologyGrant-only
- FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH23momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Single cell dark matter in the context of HIV and substance use
$616kJul 15, 2025NIDAFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11163774 (opens the source filing in a new tab)
- R01
Single cell dark matter in the context of HIV and substance use
$589kJul 15, 2025NIDAFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11372072 (opens the source filing in a new tab)
- R56
The Role of Transposable Elements in Healthy Aging and in Alzheimer's Disease
$346kSep 15, 2022NIAFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11321491 (opens the source filing in a new tab)
- R01
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
$108kMay 1, 2021NCIFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11381493 (opens the source filing in a new tab)
- R01
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
$1.1MMay 1, 2021NCIFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11192376 (opens the source filing in a new tab)
- R01
Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuseand Aging on Cognitive Impairment
$739kJul 15, 2020NIDAFEINSTEIN INSTITUTE FOR MEDICAL RESEARCHNIH RePORTER · 11234379 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources